TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 1.5nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 2.90nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 3.80nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 4.5nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 4.5nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 5nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 6nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 6.20nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 6.70nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 6.90nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 6.90nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 16nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 18nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 28nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 48nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 129nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 147nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 173nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 1.83E+4nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Research Institute Of Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataKi: 2.17E+4nMAssay Description:Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserineMore data for this Ligand-Target Pair
Affinity DataIC50: 0.25nMAssay Description:Inhibition of human cathepsin LMore data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 9.10nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Inhibition of human cathepsin SMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of human cathepsin SMore data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Inhibition of SARS-CoV-2 3CL protease by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair
Affinity DataIC50: 86nMAssay Description:Pure SARS-CoV-2 3CLP was obtained as previously described in detail, and the enzymatic activity was confirmed according to an established protocol; s...More data for this Ligand-Target Pair